For the first time, the U.S. government could have the power to negotiate prices for some of the costliest drugs covered under Medicare. The proposed legislation would also help Medicare recipients by imposing penalties against drug manufacturers who raise prices too quickly and removing some copay requirements. Julie Rovner of Kaiser Health News joins Laura Barrón-López to discuss.
Stream your PBS favorites with the PBS app: https://to.pbs.org/2Jb8twG
Find more from PBS NewsHour at https://www.pbs.org/newshour
Subscribe to our YouTube channel: https://bit.ly/2HfsCD6
Follow us:
Facebook: http://www.pbs.org/newshour
Twitter: http://www.twitter.com/newshour
Instagram: http://www.instagram.com/newshour
Subscribe:
PBS NewsHour podcasts: https://www.pbs.org/newshour/podcasts
Newsletters: https://www.pbs.org/newshour/subscribe
Stream your PBS favorites with the PBS app: https://to.pbs.org/2Jb8twG
Find more from PBS NewsHour at https://www.pbs.org/newshour
Subscribe to our YouTube channel: https://bit.ly/2HfsCD6
Follow us:
Facebook: http://www.pbs.org/newshour
Twitter: http://www.twitter.com/newshour
Instagram: http://www.instagram.com/newshour
Subscribe:
PBS NewsHour podcasts: https://www.pbs.org/newshour/podcasts
Newsletters: https://www.pbs.org/newshour/subscribe
- Category
- U.S. & Canada
- Tags
- Biden agenda, Climate Change, Manchin-Schumer deal
Sign in or sign up to post comments.
Be the first to comment